New trial aims to fix low Follow-Up rates in lung cancer screening
NCT ID NCT06324110
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests whether adding care coordination services—like patient navigation and direct communication—can improve how often people get the recommended follow-up after a lung cancer screening. It involves over 6,700 participants across community clinics. The goal is to see if system-level support can boost adherence and ultimately reduce lung cancer deaths.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Patient navigation and care coordination services
- What this could lead to
- If successful, this could show that system-level support helps more people complete lung cancer screening follow-ups, potentially reducing lung cancer deaths.
- What could go wrong
- This is a behavioral intervention trial, not a drug or cure. Results depend on real-world implementation and may vary across sites or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New PET tracer could spot cancers that standard scans overlook
- Can a conversation aid empower lung cancer patients?
- Can couples coping together ease the burden of advanced cancer?
- Can a custom toolkit help indigenous smokers spot lung cancer earlier?
- Study tests if teaching doctors and patients boosts lung cancer screening
- Could a vaccine stop lung cancer in smokers? early trial launches